Skip to content

Rivaroxaban EP Impurity I

Rivaroxaban EP Impurity I

Product Description
CAT No.
ALN-R017053
CAS No.
1151893-81-0
Mol. F.
C24H21Cl2N3O7S2
Mol. Wt.
598.5
Stock
In Stock
RFQ
Chemical Name : [2-[15,95-dichloro-2,52,8-trioxo-3,7-diaza-5(3,5)-1,3-oxazolidina-1,9(2)-dithiophena-4(1,4)-benzenanonaphan-3-yl]ethoxy]acetic acid (as per EP)
Smiles : O=C(O)COCCN(C(C1=CC=C(Cl)S1)=O)C2=CC=C(N3C(O[C@@H](CNC(C4=CC=C(Cl)S4)=O)C3)=O)C=C2
Inchi : InChI=1S/C5H11NO2.ClH/c1-3-4(6)5(7)8-2;/h4H,3,6H2,1-2H3;1H/t4-;/m0./s1
Synonym : Rivaroxaban N-acyl glycolic acid (USP)

Development and validation of stability indicating UPLC method for the determination of Rivaroxaban in bulk and finished products and identification of degradation products by LCMS

By Ali, Syed Mastan; Ramachandran, D.nFrom Journal of Applicable Chemistry (Lumami, India) (2021), 10(3), 291-301

Validated LC-MS/MS method for the determination of three genotoxic impurities in rivaroxaban drug substance

By Korlakunta, Vijaya Gouri; Dasari, Vijaya Bharathi; Sharma, Hemant Kumar; Nowduri, Annapurna; Bonige, Kishore Babu; Chavakula, Ramadas – From European Journal of Biomedical and Pharmaceutical Sciences (2020), 7(8), 492-500

Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms

By Souri, Effat; Mottaghi, Siavash; Zargarpoor, Mohammad; Ahmadkhaniha, Reza; Jalalizadeh, Hassan – From Acta Chromatographica (2016), 28(3), 347-361

Request For Quotation

Related Products